tiprankstipranks
Trending News
More News >
Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
India Market
Advertisement

Amrutanjan Health Care Limited (AMRUTANJAN) Price & Analysis

Compare
0 Followers

AMRUTANJAN Stock Chart & Stats


AMRUTANJAN FAQ

What was Amrutanjan Health Care Limited’s price range in the past 12 months?
Amrutanjan Health Care Limited lowest stock price was ₹548.05 and its highest was ₹861.40 in the past 12 months.
    What is Amrutanjan Health Care Limited’s market cap?
    Amrutanjan Health Care Limited’s market cap is ₹19.64B.
      When is Amrutanjan Health Care Limited’s upcoming earnings report date?
      Amrutanjan Health Care Limited’s upcoming earnings report date is Nov 12, 2025 which is in 89 days.
        How were Amrutanjan Health Care Limited’s earnings last quarter?
        Amrutanjan Health Care Limited released its earnings results on Aug 12, 2025. The company reported ₹2.877 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.877.
          Is Amrutanjan Health Care Limited overvalued?
          According to Wall Street analysts Amrutanjan Health Care Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Amrutanjan Health Care Limited pay dividends?
            Amrutanjan Health Care Limited pays a Quarterly dividend of ₹1 which represents an annual dividend yield of 0.7%. See more information on Amrutanjan Health Care Limited dividends here
              What is Amrutanjan Health Care Limited’s EPS estimate?
              Amrutanjan Health Care Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Amrutanjan Health Care Limited have?
              Amrutanjan Health Care Limited has 29,230,630 shares outstanding.
                What happened to Amrutanjan Health Care Limited’s price movement after its last earnings report?
                Amrutanjan Health Care Limited reported an EPS of ₹2.877 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.996%.
                  Which hedge fund is a major shareholder of Amrutanjan Health Care Limited?
                  Currently, no hedge funds are holding shares in IN:AMRUTANJAN

                  Company Description

                  Amrutanjan Health Care Limited

                  Amrutanjan Health Care Limited (AMRUTANJAN) is a prominent Indian company operating in the healthcare sector. Founded in 1893, the company specializes in pain management solutions, offering a wide array of products including pain balms, healthcare products, and personal hygiene items. Amrutanjan is renowned for its flagship product, the Amrutanjan Pain Balm, which has become a household name across India. Besides pain relief, the company has diversified into other segments such as beverages and hygiene, with a focus on expanding its consumer base and product offerings.

                  Amrutanjan Health Care Limited (AMRUTANJAN) Earnings & Revenues

                  AMRUTANJAN Stock 12 Month Forecast

                  Average Price Target

                  ₹778.00
                  ▲(15.77% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"575":"₹575","633":"₹633","691":"₹691","749":"₹749","807":"₹807"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹778.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹778.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹778.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[575,633,691,749,807],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,724.5,728.6153846153846,732.7307692307693,736.8461538461538,740.9615384615385,745.0769230769231,749.1923076923077,753.3076923076923,757.4230769230769,761.5384615384615,765.6538461538462,769.7692307692307,773.8846153846154,{"y":778,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,724.5,728.6153846153846,732.7307692307693,736.8461538461538,740.9615384615385,745.0769230769231,749.1923076923077,753.3076923076923,757.4230769230769,761.5384615384615,765.6538461538462,769.7692307692307,773.8846153846154,{"y":778,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,724.5,728.6153846153846,732.7307692307693,736.8461538461538,740.9615384615385,745.0769230769231,749.1923076923077,753.3076923076923,757.4230769230769,761.5384615384615,765.6538461538462,769.7692307692307,773.8846153846154,{"y":778,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":758.83,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":806.23,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":792.11,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":757.96,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":739.62,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":719.86,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":663.15,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":576.85,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":642.85,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":692.8,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":719,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":724.5,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":724.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Indoco Remedies Limited
                  Krsnaa Diagnostics Limited
                  TTK Healthcare Limited
                  Zota Health Care Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis